122 related articles for article (PubMed ID: 32462905)
1. Prognostic significance of C-MYC dysregulation in esophageal squamous cell carcinoma: a meta-analysis.
Shi X; Zhou R; Zheng L; Jiang M
Biomark Med; 2020 May; 14(7):599-609. PubMed ID: 32462905
[No Abstract] [Full Text] [Related]
2. Prognostic implications of
Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
4. The effect of Glut1 and c-myc on prognosis in esophageal squamous cell carcinoma of Kazakh and Han patients.
Zhou YX; Zhou KM; Liu Q; Wang H; Wang W; Shi Y; Ma YQ
Future Oncol; 2018 Aug; 14(18):1801-1815. PubMed ID: 29629851
[TBL] [Abstract][Full Text] [Related]
5. ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis.
Ma S; Lu CC; Yang LY; Wang JJ; Wang BS; Cai HQ; Hao JJ; Xu X; Cai Y; Zhang Y; Wang MR
J Exp Clin Cancer Res; 2018 Aug; 37(1):183. PubMed ID: 30081903
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of c-MYC Amplification in Esophageal Squamous Cell Carcinoma.
Huang J; Jiang D; Zhu T; Wang Y; Wang H; Wang Q; Tan L; Zhu H; Yao J; Hou Y
Ann Thorac Surg; 2019 Feb; 107(2):436-443. PubMed ID: 30273571
[TBL] [Abstract][Full Text] [Related]
7. Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma.
Zhang X; Xu Y; He C; Guo X; Zhang J; He C; Zhang L; Kong M; Chen B; Zhu C
J Surg Oncol; 2015 Jun; 111(7):834-9. PubMed ID: 25919911
[TBL] [Abstract][Full Text] [Related]
8. miR-760 exerts an antioncogenic effect in esophageal squamous cell carcinoma by negatively driving fat metabolism via targeting c-Myc.
Yang X; Zhang C; Tie H; Luo J; Wang Y; Wu Q
J Cell Biochem; 2020 Apr; 121(4):2950-2961. PubMed ID: 31709636
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of c-MYC in esophageal squamous cell carcinoma.
Lian Y; Niu X; Cai H; Yang X; Ma H; Ma S; Zhang Y; Chen Y
Tumour Biol; 2017 Jul; 39(7):1010428317715804. PubMed ID: 28671049
[TBL] [Abstract][Full Text] [Related]
10. Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell carcinoma.
Huang J; Song Q; Wang H; Wang H; Xu C; Wang X; Jiang Z; Wang Y; Xu Y; Su J; Zeng H; Tan L; Zhu H; Jiang D; Hou Y
Hum Pathol; 2018 Oct; 80():210-218. PubMed ID: 29936056
[TBL] [Abstract][Full Text] [Related]
11. Association between positive murine double minute 2 expression and clinicopathological characteristics of esophageal squamous cell carcinoma: a meta-analysis.
Chen JY; Yang H; Wen J; Luo KJ; Liu QW; Lei JY; Zhen YZ; Fu JH
Dis Esophagus; 2016 Oct; 29(7):856-863. PubMed ID: 25873358
[TBL] [Abstract][Full Text] [Related]
12. Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression.
Xie Z; Li T; Huang B; Liu S; Zhang L; Zhang Q
Technol Cancer Res Treat; 2020; 19():1533033820928117. PubMed ID: 32441221
[TBL] [Abstract][Full Text] [Related]
13. The chromosome 11q13.3 amplification associated lymph node metastasis is driven by miR-548k through modulating tumor microenvironment.
Zhang W; Hong R; Li L; Wang Y; Du P; Ou Y; Zhao Z; Liu X; Xiao W; Dong D; Wu Q; Chen J; Song Y; Zhan Q
Mol Cancer; 2018 Aug; 17(1):125. PubMed ID: 30131072
[TBL] [Abstract][Full Text] [Related]
14. Endoplasmic reticulum-localized ECM1b suppresses tumor growth and regulates MYC and MTORC1 through modulating MTORC2 activation in esophageal squamous cell carcinoma.
Yu VZ; Ko JMY; Ning L; Dai W; Law S; Lung ML
Cancer Lett; 2019 Oct; 461():56-64. PubMed ID: 31319137
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and clinicopathological significance of
Wang Y; Wu Y; Li J; Lai Y; Zhou K; Che G
Ann Transl Med; 2019 Nov; 7(22):669. PubMed ID: 31930070
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and Prognostic Significance of
Wang X; Liu D; Yang J
Genet Test Mol Biomarkers; 2022 Jun; 26(6):331-339. PubMed ID: 35763383
[No Abstract] [Full Text] [Related]
17. Prognostic value of osteopontin expression in esophageal squamous cell carcinoma: A meta-analysis.
Wang Y; Lu Y; Xu W; Wang Y; Wu Y; Che G
Pathol Res Pract; 2019 Oct; 215(10):152571. PubMed ID: 31387806
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of NS1-BP expression in esophageal squamous cell carcinoma].
Ren K; Qian D; Wang YW; Pang QS; Zhang WC; Yuan ZY; Wang P
Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):21-27. PubMed ID: 29365413
[No Abstract] [Full Text] [Related]
19. Exosomal FMR1-AS1 facilitates maintaining cancer stem-like cell dynamic equilibrium via TLR7/NFκB/c-Myc signaling in female esophageal carcinoma.
Li W; Zhang L; Guo B; Deng J; Wu S; Li F; Wang Y; Lu J; Zhou Y
Mol Cancer; 2019 Feb; 18(1):22. PubMed ID: 30736860
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte-to-monocyte ratio in esophageal squamous cell carcinoma prognosis.
Hu G; Liu G; Ma JY; Hu RJ
Clin Chim Acta; 2018 Nov; 486():44-48. PubMed ID: 30028962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
